4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000020
Chief Medical Officer sold 1,708 shares at $21.64 ($36,961)
- Chief Medical Officer acquired 5,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-20 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,750 | 33,619 | D | ||
| 2024-01-24 | Sale : show line 2 in the form 10b5-1 | −1,708 | $21.64 | $36,961 | 31,911 | D |
| Open-market sales · 1,708 sh · avg $21.64 · $36,961 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-20 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −5,750 | 0 | D |
Loading xslF345X05/wk-form4_1706131453.xml…